Pomerantz LLP Appointed Lead Counsel in McDermott International Securities Litigation

On June 5, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit filed against McDermott International.

Pomerantz Fights Forced Arbitration

Pomerantz’s recently filed intervention motion in a New Jersey federal court litigation marks the first court test of the legality of mandatory shareholder arbitration.

Pomerantz LLP Appointed Lead Counsel in WuXi PharmaTech (Cayman) Inc. Securities Class Action

On March 28, 2019, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against WuXi PharmaTech (Cayman) Inc. (“WuXi” or the “Company”) and certain of its officers and directors.

Pomerantz LLP Appointed Lead Counsel in CVS Health Corporation Securities Litigation

Pomerantz LLP was appointed Co-Lead Counsel in a class action law suit filed against CVS Health Corporation.

Pomerantz LLP Appointed Lead Counsel in Aveo Pharmaceuticals Securities Litigation

Pomerantz LLP was appointed lead counsel in a class action lawsuit filed against Aveo Pharmaceuticals.

Pomerantz LLP Appointed Lead Counsel in Lewis v. YRC Worldwide Inc. Securities Litigation

Pomerantz LLP was appointed lead counsel in a class action lawsuit filed against YRC Worldwide, Inc.

Pomerantz Ranked #1 in 2018 Settlements

Pomerantz LLP was ranked #1 in both Total Settlement Amount and Number of Settlements for 2018 by SCAS.

Pomerantz LLP Appointed Lead Counsel in Bellicum Pharmaceuticals Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Bellicum Pharmaceuticals, Inc.

Pomerantz LLP Appointed Lead Counsel in Allergan PLC Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Allergan plc.

Pomerantz LLP Appointed Lead Counsel in Ormat Technologies, Inc. Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Ormat Technologies, Inc.

Pomerantz LLP Appointed Co-Lead Counsel in Philip Morris International Inc. Securities Litigation

Pomerantz LLP was appointed Co-Lead Counsel in a class action lawsuit filed against Philip Morris International Inc.

Pomerantz LLP Appointed Lead Counsel in Edison International Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Edison International and certain of its officers.

Pomerantz LLP Appointed Lead Counsel in PolarityTE, Inc. Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against PolarityTE, Inc. and certain of its officers.

Pomerantz Achieves Settlement with Barclays PLC

Pomerantz, as sole Lead Counsel, has achieved a $27 million settlement on behalf of the Class in Strougo v. Barclays PLC, which is pending court approval.

Pomerantz LLP Appointed Lead Counsel in Namaste Technologies, Inc. Securities Litigation

On January 22, 2019, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit filed against Namaste Technologies, Inc. and certain of its officers.

Pomerantz LLP: 2018 Securities Practice Group of the Year

Pomerantz LLP was awarded Law360's 2018 Securities Group of the Year. These awards honor the law firms behind the litigation wins and major deals that resonated throughout the legal industry in the past year.

Jennifer Pafiti Named a 2019 Southern California Rising Star

Pomerantz Partner Jennifer Pafiti has been selected to the Super Lawyers 2019 Southern California Rising Stars list, an honor reserved for those lawyers who exhibit excellence in practice. Only 2.5% of attorneys in Southern California receive this distinction.

Pomerantz LLP Awarded Law360's 2018 Securities Practice Group of the Year Award

Law360 announced the winners of its 2018 Practice Group of the Year awards, honoring law firms behind the litigation wins and major deals in the legal industry through the past year. Pomerantz earned Securities Practice Group of the Year and sits as one of the top three plaintiffs’ firms.